Form 4: Rocket Pharmaceuticals Insider Sells Shares for Tax Withholding

Rocket Pharmaceuticals officer John Militello sold shares to cover tax obligations related to vesting Restricted Stock Units.

Summary

• John Militello, Vice President of Finance, Treasurer, and Principal Accounting Officer at Rocket Pharmaceuticals, Inc., reported a transaction on May 19, 2026.
• Militello sold 3,840 shares of common stock at a price of $3.014 per share.
• The sale was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following this transaction, Militello beneficially owns 89,780 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a routine event for covering tax obligations related to equity compensation and does not signal a change in the insider's view of the company's fundamental value.

Negatives

• Insider selling can sometimes be perceived negatively by the market, although in this case, it was for tax withholding purposes.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it solely reports a past transaction.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. Sales for tax withholding are common events for executives receiving equity compensation and are generally not indicative of a negative view on the company's prospects, unlike sales for other reasons.

Stakeholder Impact

• Shareholders: The sale is for tax withholding, so it does not represent a sale based on negative company outlook, which is generally positive for shareholder sentiment.
• Management: The transaction fulfills tax obligations for the reporting person.

Key Dates

Keywords

Form 4, Insider Trading, Rocket Pharmaceuticals, RCKT, Stock Sale, Tax Withholding, Restricted Stock Units, RSUs, Beneficial Ownership